1. MARKETS
  2. SECTOR : FOOD, BEVERAGES & TOBACCO
  3. INDUSTRY : OTHER FOOD & BEVERAGES
  4. MUKKA PROTEINS LTD.
Mukka Proteins Ltd.
NSE: MUKKA | BSE: 544135

Mukka Proteins Live Share Price Today, Share Analysis and Chart

aboutMukka Proteins Ltd. (MUKKA) is a key player in the Indian marine protein industry, specializing in the manufacture and export of fishmeal, fish oil, and fish-soluble paste. With an estimated 25%–30% market share in the Indian fishmeal and fish oil se... Read More
Ask AI about Mukka Proteins
24.17-0.19(-0.78%)
153.6K
NSE+BSE Volume

NSE 02 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Mid-range PerformerThese stocks have affordable valuations, but mid range financials and momentumView SimilarEmbed DVM

Mukka Proteins Stock Price Analysis

Day Price Range

-0.8% 1 Day return
24.2 (LTP)
23.824.8
LowHigh

Week Price Range

-1.8% 1 Week return
24.2 (LTP)
23.725.1
LowHigh

Month Price Range

-6.0% 1 Month return
24.2 (LTP)
2330.2
LowHigh

52 Week Price Range

-4.0% 1 Year return
24.2 (LTP)
18.333.3
LowHigh

Mukka Proteins Technical Analysis

Mukka Proteins EMA & SMA

Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
5 Day24.5
10 Day25
12 Day25.2
20 Day25.7
26 Day26.0
50 Day26.2
100 Day25.7
200 Day25.5

Mukka Proteins Delivery And Volume

Daily Avg. Delivery Volume %
02 Nov, 2026100.0%
Week100.0%
Month100.0%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Mukka Proteins Resistance and Support

24.24
Pivot
First Resistance24.7
Second Resistance25.2
Third Resistance25.7
First Support23.7
Second Support23.3
Third Support22.8
Day RSI38.2
Day MACD-0.8
Day MFI53
Day MACD Signal Line-0.6

Mukka Proteins Beta

1 Month1.1
1 Year1.1
3 Month0.9
3 Year-

Mukka Proteins Price Change Analysis

↓-6.0%
Over 1 Month
LowHigh
23.030.3
↑7.2%
Over 3 Months
LowHigh
22.733.3
↑0.6%
Over 6 Months
LowHigh
2133.3
↓-4.0%
Over 1 Year
LowHigh
18.333.3

Mukka Proteins Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Mohammed Haris KPromoter90,686,80030.2 %
Craft Emerging Market Fund Pcc- Elite Capital FundFii3,571,6601.2 %
HufPublic2,013,9040.7 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Mukka Proteins Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
HRTI PRIVATE LIMITEDBulkSell16 Jul 202453.164,423,136NSE
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED .BulkSell16 Jul 202454.061,984,995NSE
GRAVITON RESEARCH CAPITAL LLPBulkSell16 Jul 202453.042,950,216NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkSell16 Jul 202453.622,407,387NSE
DIPAN MEHTA COMMODITIES PRIVATE LIMITEDBulkSell16 Jul 202453.931,668,985NSE
GRAVITON RESEARCH CAPITAL LLPBulkPurchase16 Jul 202452.962,950,216NSE
HRTI PRIVATE LIMITEDBulkPurchase16 Jul 202453.144,505,648NSE
DIPAN MEHTA COMMODITIES PRIVATE LIMITEDBulkPurchase16 Jul 202454.241,768,489NSE
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED .BulkPurchase16 Jul 202456.061,984,995NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkPurchase16 Jul 202453.592,407,387NSE

Mukka Proteins Corporate Actions

Mukka Proteins Board Meetings

Mukka Proteins past and upcoming board meetings.

#Ex-Date
PurposeNotes
112 Aug 2026
Quarterly Results-
212 Jun 2026
To consider Funds Raising & OthersTo consider other business matters.
315 May 2026
Audited Results & Raising of funds-
412 Feb 2026
Quarterly Results(Revised)
512 Nov 2025
Quarterly Results-

Mukka Proteins Research Reports

Mukka Proteins research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
127 Feb 2024Ventura--IPO Subscribe--%pdf

Mukka Proteins Corporate Filings

Mukka Proteins BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
02 Nov 2026
Mukka Proteins Ltd - 544135 - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended 30Th September 2026
Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended 30th September 2026
PDF
27 Oct 2026
Mukka Proteins Ltd - 544135 - Intimation Of US FDA Registration.
Intimation of US FDA Registration.
PDF
09 Oct 2026
Mukka Proteins Ltd - 544135 - Intimation Of Commencement Of Commercial Production By Overseas Subsidiary.
Intimation of commencement of commercial production by overseas subsidiary.
PDF
09 Oct 2026
Mukka Proteins Ltd - 544135 - Intimation Of Giving Corporate Guarantee And Security By The Company.
Intimation of giving corporate guarantee and security by the Company.
PDF
07 Oct 2026
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating.
PDF

Mukka Proteins DocumentsAsk MarketMind AI

Mukka Proteins Annual Reports

Mukka Proteins financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026
2025Annual Report Mar-2025
2024Annual Report Mar-2024

Mukka Proteins Credit Ratings

Mukka Proteins credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
06 Oct 2026care ratingsMukka Proteins Limited
25 May 2026care ratingsMukka Proteins Limited
07 Jan 2026care ratingsMukka Proteins Limited
29 Jan 2025icra ratingsMukka Proteins LimitedRatings withdrawn
14 Jan 2025care ratingsMukka Proteins Limited

Mukka Proteins Investor Presentations

Mukka Proteins investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
22 May 2026Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Investor Presentation
13 Feb 2026Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Investor Presentation

Mukka Proteins - Company Profile

Mukka Proteins Management Structure

Mukka Proteins management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mehaboobsab Mahmadgous ChalyalCompany Secretary,Compliance Officer-Mar 26
Mr. Mohammad ShareefGeneral Manager(Finance & Accounts)-Mar 26
Mr. Shibu Karumathy OusephGeneral Manager(Production,Operations)-Mar 26
Kalandan Mohammed HarisExecutive Director,Managing Director,Chief Executive Officer-Mar 26
Kalandan Mohammed AlthafExecutive Director,Whole Time Director,Chief Financial Officer,Co-Founder & Promoter-Mar 26
Kalandan Mohammad ArifExecutive Director,Whole Time Director,Chief Operating Officer-Mar 26

Mukka Proteins Board of Directors

Mukka Proteins Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Kalandan Mohammed HarisED / MD / CEO / Promoter144Mar 26
Kalandan Mohammed AlthafED / WTD / CFO / Promoter96Mar 26
Kalandan Mohammad ArifWhole Time Director & COO96Mar 26
Hamad BavaIndependent Non Exe. Director1.8Mar 26
Karkala Shankar Balachandra RaoChairman & Independent Directo1.6Mar 26
Narendra Surendra KamathIndependent Non Exe. Director1.3Mar 26
Kalandan Abdul RazakNon-Exec & Non-Independent Dir1.2Mar 26
Umaiyya BanuNon-Exec & Non-Independent Dir0.9Mar 26
Mehaboobsab Mahmadgous ChalyalCompany Sec. & Compli. Officer-Mar 26

About the company - Business Profile

Mukka Proteins Ltd. (MUKKA) is a key player in the Indian marine protein industry, specializing in the manufacture and export of fishmeal, fish oil, and fish-soluble paste. With an estimated 25%–30% market share in the Indian fishmeal and fish oil segment, the company serves as a vital supplier to the aquaculture, poultry, and livestock industries globally. Mukka Proteins has also expanded into alternate proteins through insect-based products and entered the frozen seafood sector, positioning itself as an integrated animal protein and sustainability platform.

Key Points

  • Key Facts: Founded in 1977 as a partner firm and incorporated in its current form in 2010, the company is headquartered in Mangaluru, Karnataka. It listed on the NSE and BSE on March 7, 2024. The company is promoter-led, with Mr. Kalandan Mohammed Haris serving as Managing Director and CEO.
  • Operations and Resources: The company operates multiple manufacturing facilities, including two units in Karnataka (Mangaluru and Ullal) and a presence in Gujarat. Internationally, it has established units in Oman. Its total installed capacity for fishmeal, fish oil, and paste stands at 2,64,390 MT per year.
  • Market and Significance: Mukka Proteins exports to over 25 countries, including China, Chile, Saudi Arabia, and South Korea. Its products are essential high-protein ingredients for aq꿮d (shrimp and fish) and poultry feed. It is one of the few Indian companies to commercialize insect protein (insect meal and oil).
  • Sustainability and Innovation: The company focuses on waste-to-value solutions, utilizing fish by-products to produce nutrient-rich feed. It has a dedicated R&D effort for nutritional quality enhancement and has secured a significant order of ₹474.89 crore for the treatment of legacy leachate, reflecting its diversification into environmental services.

Business Model and Segment Performance Mukka Proteins follows an integrated business model that spans sourcing raw fish, processing it into high-protein ingredients, and global distribution. The company excels in large-scale steam-sterilized fishmeal production and has a first-mover advantage in the Indian insect protein market.

Revenue Breakdown (FY 2024-25 Annual Numbers):

  • Standalone Revenue: ₹8,867.43 million (compared to ₹12,685.43 million in FY 2023-24).
  • Consolidated Revenue: ₹10,064.16 million (compared to ₹13,798.29 million in FY 2023-24).
  • Net Profit (Consolidated): ₹480.97 million for FY 2024-25.
  • Geographical Reach: Exports contribute a significant portion of revenue, with a presence in over 25 countries across the Far East, Middle East, and South America.

Key Products and Technology:

  • Fish Meal: High-protein ingredient for aquaculture and poultry.
  • Fish Oil: Rich in Omega-3 fatty acids, used in aq꿮d, pharmaceuticals, and industrial applications.
  • Insect Protein: Commercialized through subsidiary Ento Proteins Pvt Ltd, targeting alternate protein markets.
  • Facility Advancement: Implementation of automated blending units and quality testing laboratories as per international standards (GMP+ B2 Certification).

Strategic Initiatives and Outlook:

  • Acquisitions: Recently acquired GSM, FABBCO, Mukka Frozen, and MPL HRC Ecosolutions to strengthen its footprint.
  • Consolidation: Plans to make Ento Proteins and HMPPL wholly-owned subsidiaries.
  • Expansion: Approved capacity expansion in Bengaluru and strengthening of its carbon credit portfolio through Verra-listed projects.
  • Future Outlook: Focus remains on expanding the product portfolio into higher-margin segments like frozen seafood and leveraging waste management contracts for steady cash flows.

References

  1. Investor Presentation Feb 2026
  2. Annual Report May 2025
  3. Annual Report May 2024
  4. Quarterly Results Nov 2025

Mukka Proteins FAQ

Mukka Proteins today is trading in the red, down by 0.78% at ₹24.17.
Mukka Proteins is currently trading down 0.78% on an intraday basis. In the past week the stock fell 1.75%. Stock has been up 7.23% in the past quarter and fell 4.01% in the past year. You can view this in the share price history/seasonality section.
Mukka Proteins is listed on NSE with the ticker MUKKA and on BSE as 544135. It's currently trading on NSE at a share price of ₹24.17 and on BSE with a share price of ₹24.53.
The market cap of Mukka Proteins is ₹725.1 Cr. as of Nov 02, 2026.
Mukka Proteins has never announced any dividend since the time of its listing on the BSE/NSE exchanges.
Mukka Proteins has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Mukka Proteins reported ₹491.25 Cr. in revenue, ₹18.89 Cr. in net profit, and ₹49.57 Cr. in EBITD as of Aug 12, 2026 for Q1 FY26-27.
There are no analyst predictions for stock price target for Mukka Proteins.
The PE ratio of Mukka Proteins is 10.49 as of Nov 02, 2026.
The PB ratio of Mukka Proteins is 1.4 as of Nov 02, 2026.
There are no analyst reports for Mukka Proteins.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.